Neurocritical Care

, 9:177

Effect of Treatment of Elevated Blood Pressure on Neurological Deterioration in Patients with Acute Intracerebral Hemorrhage

  • M. Fareed K. Suri
  • Jose I. Suarez
  • Tina C. Rodrigue
  • Osama O. Zaidat
  • Gabriela Vazquez
  • Andrew Wensel
  • Warren R. Selman
Original Article



Treatment of elevated blood pressure after acute intracerebral hemorrhage (ICH) is controversial. There is a risk of hematoma expansion with elevated blood pressure, and risk of ischemia with blood pressure control. This study was done to determine the effect of blood pressure control on outcome.


We retrospectively studied 122 patients with ICH. We collected 24-h blood pressure readings on all patients. The Glasgow Coma Score (GCS) at baseline and at 24 h was used to determine neurological deterioration (GCS decline ≥ 2). Baseline computerized tomography (CT) scans were reviewed for hematoma volume, intraventricular hemorrhage, and location of hemorrhage. Drops in systolic blood pressure and mean arterial pressures over 24 h were divided in quartiles to determine the risk of neurological deterioration among quartiles. A logistic regression model was used to determine the association between variables of interest and neurological deterioration.


Neurological deterioration was observed in 12 patients (10%). Baseline blood pressure and GCS were only two variables significantly different among quartiles of blood pressure drop. Multivariable adjusted analysis for these variables demonstrated significant trend toward reduced neurological deterioration with maximum blood pressure drop (systolic or mean). The risk of neurological deterioration was significantly lower in the quartile of maximum drop of systolic (odds ratio [OR] 0.02, 95% confidence interval [CI] 0.0–0.68) or mean (OR 0.03, 95% CI 0.0–0.98) blood pressure when compared to the quartile with least drop.


This study supports that reduction of blood pressure in patients with acute ICH is safe and suggests that aggressive reduction might reduce the risk of neurological deterioration in first 24 h of admission.


Intracerebral hemorrhage Outcome Hypertension Neurological deterioration Hypertensive emergency 


  1. 1.
    Qureshi AI, Ezzeddine MA, Nasar A, et al. Prevalence of elevated blood pressure in 563704 adult patients with stroke presenting to the ED in the United States. Am J Emerg Med. 2007;25:32–8.PubMedCrossRefGoogle Scholar
  2. 2.
    Powers WJ. Acute hypertension after stroke: the scientific basis for treatment decisions. Neurology. 1993;43:461–7.PubMedGoogle Scholar
  3. 3.
    Broderick JP, Brott TG, Tomsick T, Barsan W, Spilker J. Ultra-early evaluation of intracerebral hemorrhage. J Neurosurg. 1990;72:195–9.PubMedCrossRefGoogle Scholar
  4. 4.
    Chen ST, Chen SD, Hsu CY, Hogan EL. Progression of hypertensive intracerebral hemorrhage. Neurology. 1989;39:1509–14.PubMedGoogle Scholar
  5. 5.
    Kazui S, Naritomi H, Yamamoto H, Sawada T, Yamaguchi T. Enlargement of spontaneous intracerebral hemorrhage. Incidence and time course. Stroke. 1996;27:1783–7.PubMedGoogle Scholar
  6. 6.
    Ohwaki K, Yano E, Nagashima H, Hirata M, Nakagomi T, Tamura A. Blood pressure management in acute intracerebral hemorrhage: relationship between elevated blood pressure and hematoma enlargement. Stroke. 2004;35:1364–7.PubMedCrossRefGoogle Scholar
  7. 7.
    Maruishi M, Shima T, Okada Y, Nishida M, Yamane K. Involvement of fluctuating high blood pressure in the enlargement of spontaneous intracerebral hematoma. Neurol Med Chir. 2001;41:300–5.CrossRefGoogle Scholar
  8. 8.
    Broderick J, Connolly S, Feldmann E, et al. Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: a guideline from the American heart association/American stroke association stroke council, high blood pressure research council, and the quality of care and outcomes in research interdisciplinary working group: the American academy of neurology affirms the value of this guideline as an educational tool for neurologists. Stroke. 2007;38:2001–23.Google Scholar
  9. 9.
    Mayer SA, Sacco RL, Shi T, Mohr JP. Neurological deterioration in noncomatose patients with intracerebral hemorrhage. Neurology. 1994;44:1379–84.PubMedGoogle Scholar
  10. 10.
    Verbeke G, Molenberghs G. Linear mixed models for longitudinal data. New York: Springer; 2000.Google Scholar
  11. 11.
    Diggle P. Analysis of longitudinal data. 2nd ed. Oxford/New York: Oxford University Press; 2002.Google Scholar
  12. 12.
    Meyer JS, Bauer RB. Medical treatment of spontaneous intracranial hemorrhage by the use of hypotensive drugs. Neurology. 1962;12:36–47.PubMedGoogle Scholar
  13. 13.
    Dandapani BK, Suzuki S, Kelley RE, Reyes-Iglesias Y, Duncan RC. Relation between blood pressure and outcome in intracerebral hemorrhage. Stroke. 1995;26:21–4.PubMedGoogle Scholar
  14. 14.
    Qureshi AI, Bliwise DL, Bliwise NG, Akbar MS, Uzen G, Frankel MR. Rate of 24-hour blood pressure decline and mortality after spontaneous intracerebral hemorrhage: a retrospective analysis with a random effects regression model. Crit Care Med. 1999;27:480–5.PubMedCrossRefGoogle Scholar
  15. 15.
    Qureshi AI, Mohammad YM, Yahia AM, et al. A Prospective multicenter study to evaluate the feasibility and safety of aggressive antihypertensive treatment in patients with acute intracerebral hemorrhage. J Intensive Care Med. 2005;20:34.PubMedCrossRefGoogle Scholar
  16. 16.
    Anderson C. The Intensive Blood Pressure Reduction in Acute Cerebral Hemorrhage Trial (INTERACT): results of the Vanguard Phase. In: International stroke conference. New Orleans, Louisiana; 2008.Google Scholar
  17. 17.
    Qureshi AI. Acute blood pressure management—the North American perspective: insights from the ATACH trial. In: International stroke conference. New Orleans, Louisiana; 2008.Google Scholar
  18. 18.
    Powers WJ, Zazulia AR, Videen TO, et al. Autoregulation of cerebral blood flow surrounding acute (6 to 22 hours) intracerebral hemorrhage. Neurology. 2001;57:18–24.PubMedCrossRefGoogle Scholar
  19. 19.
    Qureshi AI, Wilson DA, Hanley DF, Traystman RJ. Pharmacologic reduction of mean arterial pressure does not adversely affect regional cerebral blood flow and intracranial pressure in experimental intracerebral hemorrhage. Crit Care Med. 1999;27:965–71.PubMedCrossRefGoogle Scholar
  20. 20.
    Leira R, Davalos A, Silva Y, et al. Early neurologic deterioration in intracerebral hemorrhage. Predictors and associated factors. Neurology. 2004;63:461–7.PubMedGoogle Scholar
  21. 21.
    Brott T, Broderick J, Kothari R, et al. Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke. 1997;28:1–5.PubMedGoogle Scholar

Copyright information

© Humana Press Inc. 2008

Authors and Affiliations

  • M. Fareed K. Suri
    • 1
  • Jose I. Suarez
    • 2
  • Tina C. Rodrigue
    • 3
  • Osama O. Zaidat
    • 4
  • Gabriela Vazquez
    • 1
  • Andrew Wensel
    • 3
  • Warren R. Selman
    • 3
  1. 1.Clinical Trials Division, Zeenat Qureshi Stroke Research CenterUniversity of MinnesotaMinneapolisUSA
  2. 2.Division of Vascular Neurology and Neurocritical Care, Department of NeurologyBaylor College of MedicineHoustonUSA
  3. 3.Neurological Institute, Neurosciences Critical CareUniversity Hospitals of ClevelandClevelandUSA
  4. 4.Divison of Endovascular Neurology, Department of NeurologyMedical College of WisconsinMilwaukeeUSA

Personalised recommendations